Newborn screening of duchenne muscular dystrophy specifically targeting deletions amenable to exon-skipping therapy
Abstract Duchenne Muscular Dystrophy (DMD) is a lethal progressive muscle-wasting disease. New treatment strategies relying on DMD gene exon-skipping therapy have recently been approved and about 30% of patients could be amenable to exon 51, 53 or 45 skipping. We evaluated the spectrum of deletions...
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | article |
| Language: | EN |
| Published: |
Nature Portfolio
2021
|
| Subjects: | |
| Online Access: | https://doaj.org/article/27dddf18d89948a6a54653f693dce78e |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Be the first to leave a comment!